386 related articles for article (PubMed ID: 31916006)
1. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
Todaro B
J Natl Compr Canc Netw; 2012 Apr; 10(4):487-92. PubMed ID: 22491047
[TBL] [Abstract][Full Text] [Related]
4. Secondary and cumulative meta-analysis of olanzapine for antiemetic prophylaxis for chemotherapy-induced nausea and vomiting: do we still need to study its effectiveness?
Chiu L; Chow R; DeAngelis C; Lock M; Simone CB
Ann Palliat Med; 2021 Mar; 10(3):2540-2547. PubMed ID: 33440973
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy.
Serafimovska T; Darkovska-Serafimovska M; Stefkov G; Arsova-Sarafinovska Z; Balkanov T
Folia Med (Plovdiv); 2020 Dec; 62(4):668-678. PubMed ID: 33415919
[TBL] [Abstract][Full Text] [Related]
6. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Alderman B; Hui D; Mukhopadhyay S; Bouleuc C; Case AA; Amano K; Crawford GB; de Feo G; Sbrana A; Tanco K; To J; Garsed J; Davis M
Support Care Cancer; 2022 Dec; 31(1):39. PubMed ID: 36525085
[TBL] [Abstract][Full Text] [Related]
7. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
Tafelski S; Häuser W; Schäfer M
Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature.
Chow R; Herrstedt J; Aapro M; Chiu L; Lam H; Prsic E; Lock M; DeAngelis C; Navari RM
Support Care Cancer; 2021 Jul; 29(7):3439-3459. PubMed ID: 33442782
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.
Chow R; Chiu L; Navari R; Passik S; Chiu N; Popovic M; Lam H; Pasetka M; Chow E; DeAngelis C
Support Care Cancer; 2016 Feb; 24(2):1001-1008. PubMed ID: 26530228
[TBL] [Abstract][Full Text] [Related]
11. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Davis MP
Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Chow R; Tsao M; Chiu L; Popovic M; Milakovic M; Lam H; DeAngelis C
Ann Palliat Med; 2018 Apr; 7(2):221-233. PubMed ID: 29764184
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
Slatkin NE
J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.
Chiu L; Chow R; Popovic M; Navari RM; Shumway NM; Chiu N; Lam H; Milakovic M; Pasetka M; Vuong S; Chow E; DeAngelis C
Support Care Cancer; 2016 May; 24(5):2381-2392. PubMed ID: 26768437
[TBL] [Abstract][Full Text] [Related]
15. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic reviews.
Schussel V; Kenzo L; Santos A; Bueno J; Yoshimura E; de Oliveira Cruz Latorraca C; Pachito DV; Riera R
Phytother Res; 2018 Apr; 32(4):567-576. PubMed ID: 29168289
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.
Machado Rocha FC; Stéfano SC; De Cássia Haiek R; Rosa Oliveira LM; Da Silveira DX
Eur J Cancer Care (Engl); 2008 Sep; 17(5):431-43. PubMed ID: 18625004
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.
Tramèr MR; Carroll D; Campbell FA; Reynolds DJ; Moore RA; McQuay HJ
BMJ; 2001 Jul; 323(7303):16-21. PubMed ID: 11440936
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.
Song HJ; Seo HJ; Son H
Eur J Clin Pharmacol; 2016 Nov; 72(11):1289-1301. PubMed ID: 27526189
[TBL] [Abstract][Full Text] [Related]
20. Are cannabinoids effective for the management of chemotherapy induced nausea and vomiting?
Morales M; Corsi O; Peña J
Medwave; 2017 Dec; 17(9):e7119. PubMed ID: 29286355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]